Runzi Li
University of North Carolina at Greensboro(US)Jiangsu Hengrui Medicine (China)(CN)
Publications by Year
Research Areas
Platelet Disorders and Treatments, COVID-19 epidemiological studies, Virology and Viral Diseases, Blood groups and transfusion, Vaccine Coverage and Hesitancy
Most-Cited Works
- → A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia(2021)71 cited
- → Epidemiological Characteristics and Spatial-Temporal Clusters of Mumps in Shandong Province, China, 2005–2014(2017)41 cited
- → Forecasting the Incidence of Mumps in Zibo City Based on a SARIMA Model(2017)38 cited
- → The short-term association between meteorological factors and mumps in Jining, China(2016)36 cited
- → Adverse Events in Treating Smear-Positive Tuberculosis Patients in China(2015)28 cited
- → Using a distributed lag non-linear model to identify impact of temperature variables on haemorrhagic fever with renal syndrome in Shandong Province(2018)19 cited
- → Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study(2022)17 cited
- → Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study(2021)13 cited
- → Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study(2024)7 cited
- → Oxygenation of copper(I) complexes containing fluorine tagged tripodal tetradentate chelates: significant ligand electronic effects(2022)5 cited